BAVARIAN NORDIC A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.8 DKK | +3.26% |
|
+1.02% | -16.12% |
| Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
| Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
Business Summary
Net sales by revenue source are divided between sales of products (97.8%) and services (2.2%).
Net sales are distributed geographically as follows: the United States (36.5%), Canada (22%), France (10.5%), Germany (10.1%), Spain (6.1%), Australia (4.8%), Switzerland ( 1.5%), Sweden (1%), Chile (0.9%), Taiwan (0.8%), the United Kingdom (0.6%), Hong Kong (0.2%), Saudi Arabia (0.1%), and others (4.9%).
Number of employees: 1,379
Sales per Business
| DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Life-Saving Vaccines
100.0
%
| 3,151 | 100.0 % | 7,062 | 100.0 % | +124.14% |
Sales per region
| DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
36.5
%
| 842 | 26.7 % | 2,577 | 36.5 % | +206.24% |
Canada
22.0
%
| 197 | 6.3 % | 1,556 | 22.0 % | +688.73% |
France
10.5
%
| 268 | 8.5 % | 740 | 10.5 % | +176.02% |
Germany
10.1
%
| 650 | 20.6 % | 714 | 10.1 % | +9.83% |
Spain
6.1
%
| - | - | 430 | 6.1 % | - |
Australia
4.8
%
| 98 | 3.1 % | 338 | 4.8 % | +246.19% |
Other
4.6
%
| 285 | 9.0 % | 326 | 4.6 % | +14.38% |
Switzerland
1.5
%
| 71 | 2.3 % | 108 | 1.5 % | +51.77% |
Sweden
1.0
%
| - | - | 72 | 1.0 % | - |
Chile
0.9
%
| - | - | 65 | 0.9 % | - |
Taiwan
0.8
%
| - | - | 54 | 0.8 % | - |
United Kingdom
0.6
%
| 169 | 5.4 % | 45 | 0.6 % | -73.57% |
Denmark
0.3
%
| 19 | 0.6 % | 19 | 0.3 % | -2.07% |
Hong Kong
0.2
%
| 116 | 3.7 % | 14 | 0.2 % | -87.94% |
Saudi Arabia
0.1
%
| 100 | 3.2 % | 5 | 0.1 % | -95.18% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 57 | 98-12-31 |
Henrik Juuel
DFI | Director of Finance/CFO | 59 | 18-10-31 |
Russell Thirsk
COO | Chief Operating Officer | 56 | 22-03-31 |
| Chief Tech/Sci/R&D Officer | 60 | 20-03-31 | |
| Investor Relations Contact | - | - | |
Anu Helena Kerns
HRO | Human Resources Officer | 52 | 20-10-31 |
| Corporate Officer/Principal | 57 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anders Pedersen
BRD | Director/Board Member | 73 | 10-04-26 |
| Director/Board Member | 57 | 22-12-31 | |
Frank Verwiel
BRD | Director/Board Member | 62 | 16-04-19 |
Heidi Hunter
BRD | Director/Board Member | 66 | 22-12-31 |
Anne Eberhard
BRD | Director/Board Member | 61 | 19-04-23 |
Luc Debruyne
CHM | Chairman | 61 | 23-02-28 |
Linette Andersen
BRD | Director/Board Member | 50 | 20-12-31 |
Thomas Bennekov
BRD | Director/Board Member | 56 | 20-12-31 |
Anja Gjøl
BRD | Director/Board Member | 44 | 20-12-31 |
Karen Jensen
BRD | Director/Board Member | 65 | 20-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 78,097,834 | 77,983,471 ( 99.85 %) | 43,954 ( 0.0563 %) | 99.85 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
BAVARIAN NORDIC A/S 0.21% | 160,805 | 0.21% | 3,607,723 $ |
Company contact information
Sector
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
144.2
DKK
Average target price
264.8
DKK
Spread / Average Target
+83.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.77% | 1.61B | |
| +24.17% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.45% | 233B | |
| +6.04% | 201B | |
| -10.51% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
- Stock Market
- Equities
- BAVA Stock
- Company Bavarian Nordic A/S
